Resources
Filter by Topic
- Blogs
As the demands on real-world data teams continue to grow, with more data sources, more stakeholders, and more pressure to deliver trusted evidence faster, the...
- Blogs
Health economics and outcomes research (HEOR), epidemiology, and real-world evidence (RWE) teams are under growing pressure to deliver meaningful insights faster than ever before. As...
- Blogs
Learn what organizations must do to balance speed, transparency, governance, and innovation in an increasingly data-driven and AI-reliant environment.
- Blogs
By Stacy Justo, Meghana Shamsunder, and Marten van den Berg
- Blogs
As regulators around the world grow more comfortable with real-world data (RWD) and AI-enabled evidence generation, pharma companies are rethinking how, and when, they build...
- Blogs
As real-world data (RWD) becomes more central to healthcare decision making, evidence generation is playing an increasingly important role, from early identification to treatment optimization...
- Press Releases
Embed validated patient phenotype definitions directly into your workflow for faster insights
Panalgo Brings the Power of Machine-Learning to the Healthcare Industry Via Its Instant Health Data (IHD) Software
BOSTON, Mass. – September 15, 2020 – Panalgo, a leading healthcare analytics company, today announced the launch of its new Data Science module for Instant Health Data
Panalgo to Present at ICPE 2020
The 2020 virtual International Conference for Pharmacoepidemiology (ICPE) takes place September 16-17. Panalgo will be sharing the following research during the virtual event, please join
5 Steps To Prepare For A Third-Party Drug Price Evaluation
In this Life Science Leader article, Matt Sussman discusses important steps to take when preparing for a third party drug price evaluation. Sussman notes that
Do Research Groups Align on an Intervention’s Value? Concordance of Cost-Effectiveness Findings Between the Institute for Clinical and Economic Review and Other Health System Stakeholders
Authors: Matthew Sussman, Jeffrey C Yu, Joseph Menzin Published: Applied Health Economics Health Policy Click here to view the article.
BHE is Now Panalgo: Why We Changed Our Name and Brand
In 1996, I started Boston Health Economics (BHE) to provide professional research services to the life sciences industry, including economic modeling, database analyses and strategic
BHE Announces Rebrand to Panalgo, Continues Its Mission of Leadership in Analytics Software for Healthcare [Press Release]
BOSTON, Mass. – July 27, 2020 – BHE, a leading healthcare analytics company, is now Panalgo. The new name reflects the company’s commitment to expanding the accessibility
IHD Analytics
Put reliable, rapid analytics in the hands of more people across your organization